Women's Cancer Care

Covington, Louisiana 70433

1 studies enrolling now · 12 studies all time

What they study most

Endometrial Neoplasms, Endometrioid Adenocarcinoma, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Gastrointestinal Cancer, HER2-positive Advanced Solid Tumor, Head and Neck Cancer, High Grade Serous Carcinoma, Non Small Cell Lung Cancer, Ovarian Cancer, Ovarian Carcinoma, Ovarian Granulosa Cell Tumor

Studies at this site

• Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression — Recruiting now
• A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors — Recruiting now
• A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer — Recruiting now
• A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors — Completed
• Nirogacestat in Ovarian Granulosa Cell Tumors — Completed
• Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian — Completed
• SGI-110 in Combination With Carboplatin in Ovarian Cancer — Completed
• Batiraxcept (AVB-S6-500)/Placebo in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer — Stopped early
• A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES) — Stopped early
• A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer — Completed
• Phase II Study of Ipilimumab Monotherapy in Recurrent Platinum-sensitive Ovarian Cancer — Completed
• A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer — Stopped early